ERBB2 and breast cancer: In addition to clinical estrogen receptor subtyping, analyses performed on the molecular subtypes of breast cancer, namely, luminal A, luminal B, HER2-enriched, basal-like, and normal-like, would have been relevant in the context of this analysis, given the recognized heterogeneity of ER-positive and ER-negative tumors.